Efficacy and Safety of Crizotinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with ROS1 Rearrangement or MET Alteration: A Systematic Review and Meta-Analysis
Huy Gia Vuong, Thu Quynh Nguyen, Hoang C.B. Nguyen, Phuoc T Christie-Nguyen, An Thi Nhat Ho, Lewis Hassell
Topics & Concepts
CrizotinibMedicineROS1Internal medicineLung cancerOncologyAdverse effectMeta-analysisConfidence intervalGastroenterologyCancerAdenocarcinomaMalignant pleural effusionLung Cancer Treatments and MutationsFibroblast Growth Factor ResearchInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis